{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:54:10Z","timestamp":1791824050349,"version":"4.3.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Major Science and Technology Projects of Xinjiang Uygur Autonomous Region"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"DOI":"10.1038\/s41371-026-01245-3","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:33:30Z","timestamp":1791822810000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Potential under-recognition of primary aldosteronism in young adults with hypertension"],"prefix":"10.1038","author":[{"given":"Jianwen","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junli","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saimire","family":"Anwaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1505-8566","authenticated-orcid":false,"given":"Nanfang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,12]]},"reference":[{"key":"1245_CR1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/s2213-8587(17)30319-4","volume":"6","author":"S Monticone","year":"2018","unstructured":"Monticone S, D\u2019Ascenzo F, Moretti C, Williams TA, Veglio F, Gaita F, et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2018 ;6:41\u201350. https:\/\/doi.org\/10.1016\/s2213-8587(17)30319-4","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1245_CR2","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/s2213-8587(21)00210-2","volume":"9","author":"M Reincke","year":"2021","unstructured":"Reincke M, Bancos I, Mulatero P, Scholl UI, Stowasser M, Williams TA. Diagnosis and treatment of primary aldosteronism. Lancet Diabetes Endocrinol. 2021 ;9:876\u201392. https:\/\/doi.org\/10.1016\/s2213-8587(21)00210-2","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1245_CR3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7326\/M20-0065","volume":"173","author":"JM Brown","year":"2020","unstructured":"Brown JM, Siddiqui M, Calhoun DA, Carey RM, Hopkins PN, Williams GH, et al. The unrecognized prevalence of primary aldosteronism: a cross-sectional study. Ann Intern Med. 2020 ;173:10\u201320. https:\/\/doi.org\/10.7326\/M20-0065","journal-title":"Ann Intern Med"},{"key":"1245_CR4","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11906-022-01176-7","volume":"24","author":"T Wannachalee","year":"2022","unstructured":"Wannachalee T, Lieberman L, Turcu AF. High prevalence of autonomous aldosterone production in hypertension: how to identify and treat it. Curr Hypertens Rep. 2022 ;24:123\u201332. https:\/\/doi.org\/10.1007\/s11906-022-01176-7","journal-title":"Curr Hypertens Rep"},{"key":"1245_CR5","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1210\/clinem\/dgaf284","volume":"110","author":"GK Adler","year":"2025","unstructured":"Adler GK, Stowasser M, Correa RR, Khan N, Kline G, McGowan MJ, et al. Primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2025 ;110:2453\u201395. https:\/\/doi.org\/10.1210\/clinem\/dgaf284","journal-title":"J Clin Endocrinol Metab"},{"key":"1245_CR6","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016 ;101:1889\u2013916. https:\/\/doi.org\/10.1210\/jc.2015-4061","journal-title":"J Clin Endocrinol Metab"},{"key":"1245_CR7","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1161\/hypertensionaha.119.14359","volume":"75","author":"G Jaffe","year":"2020","unstructured":"Jaffe G, Gray Z, Krishnan G, Stedman M, Zheng Y, Han J, et al. Screening rates for primary aldosteronism in resistant hypertension: A Cohort Study. Hypertension. 2020 ;75:650\u20139. https:\/\/doi.org\/10.1161\/hypertensionaha.119.14359","journal-title":"Hypertension"},{"key":"1245_CR8","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.eprac.2021.11.085","volume":"28","author":"K Zekarias","year":"2022","unstructured":"Zekarias K, Tessier KM. Screening rate for primary aldosteronism among patients with apparent treatment-resistant hypertension: retrospective analysis of current practice. Endocr Pract. 2022 ;28:271\u20135. https:\/\/doi.org\/10.1016\/j.eprac.2021.11.085","journal-title":"Endocr Pract"},{"key":"1245_CR9","doi-asserted-by":"publisher","DOI":"10.1177\/20420188241303429","volume":"15","author":"TW Kao","year":"2024","unstructured":"Kao TW, Chen JY, Liu JH, Tseng WH, Hsieh CC, Wu VC, et al. Diagnostic efficacy of aldosterone-to-renin ratio to screen primary aldosteronism in hypertension: a systemic review and meta-analysis. Ther Adv Endocrinol Metab. 2024 ;15:20420188241303429. https:\/\/doi.org\/10.1177\/20420188241303429","journal-title":"Ther Adv Endocrinol Metab"},{"key":"1245_CR10","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1055\/s-0031-1295460","volume":"44","author":"M Stowasser","year":"2012","unstructured":"Stowasser M, Ahmed AH, Pimenta E, Taylor PJ, Gordon RD. Factors affecting the aldosterone\/renin ratio. Horm Metab Res. 2012 ;44:170\u20136. https:\/\/doi.org\/10.1055\/s-0031-1295460","journal-title":"Horm Metab Res"},{"key":"1245_CR11","doi-asserted-by":"publisher","first-page":"238","DOI":"10.2165\/00002512-199303030-00005","volume":"3","author":"JH Bauer","year":"1993","unstructured":"Bauer JH. Age-related changes in the renin-aldosterone system. physiological effects and clinical implications. Drugs Aging. 1993 ;3:238\u201345. https:\/\/doi.org\/10.2165\/00002512-199303030-00005","journal-title":"Drugs Aging"},{"key":"1245_CR12","doi-asserted-by":"publisher","first-page":"391","DOI":"10.2165\/00002512-199405050-00007","volume":"5","author":"J Belmin","year":"1994","unstructured":"Belmin J, L\u00e9vy BI, Michel JB. Changes in the renin-angiotensin-aldosterone axis in later life. Drugs Aging. 1994 ;5:391\u2013400. https:\/\/doi.org\/10.2165\/00002512-199405050-00007","journal-title":"Drugs Aging"},{"key":"1245_CR13","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/s41371-025-01006-8","volume":"39","author":"C Zhang","year":"2025","unstructured":"Zhang C, Guo Z, Yi C, Wang H, Zhang W, Zhao Y. Age- and sex-specific reference intervals for renin and aldosterone in healthy individuals in Yunnan Province, China. J Hum Hypertens. 2025 ;39:652\u20137. https:\/\/doi.org\/10.1038\/s41371-025-01006-8","journal-title":"J Hum Hypertens"},{"key":"1245_CR14","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1097\/hjh.0000000000003257","volume":"40","author":"GP Veldhuizen","year":"2022","unstructured":"Veldhuizen GP, Alnazer RM, Kroon AA, de Leeuw PW. Variability of aldosterone, renin and the aldosterone-to-renin ratio in hypertensive patients without primary aldosteronism. J Hypertens. 2022 ;40:2256\u201362. https:\/\/doi.org\/10.1097\/hjh.0000000000003257","journal-title":"J Hypertens"},{"key":"1245_CR15","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/hr.2014.129","volume":"37","author":"C Nakama","year":"2014","unstructured":"Nakama C, Kamide K, Kawai T, Hongyo K, Ito N, Onishi M, et al. The influence of aging on the diagnosis of primary aldosteronism. Hypertension Res. 2014 ;37:1062\u20137. https:\/\/doi.org\/10.1038\/hr.2014.129","journal-title":"Hypertension Res"},{"key":"1245_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1198090","volume":"10","author":"SM Nwia","year":"2023","unstructured":"Nwia SM, Leite APO, Li XC, Zhuo JL. Sex differences in the renin-angiotensin-aldosterone system and its roles in hypertension, cardiovascular, and kidney diseases. Front Cardiovasc Med. 2023 ;10:1198090. https:\/\/doi.org\/10.3389\/fcvm.2023.1198090","journal-title":"Front Cardiovasc Med"},{"key":"1245_CR17","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1161\/hypertensionaha.124.22753","volume":"81","author":"JB de Freminville","year":"2024","unstructured":"de Freminville JB, Gardini M, Cremer A, Camelli S, Baron S, Bobrie G, et al. Prevalence and risk factors for secondary hypertension in young adults. Hypertension. 2024 ;81:2340\u20139. https:\/\/doi.org\/10.1161\/hypertensionaha.124.22753","journal-title":"Hypertension"},{"key":"1245_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.622179","volume":"11","author":"L Jehpsson","year":"2020","unstructured":"Jehpsson L, Sun J, Nilsson PM, Edsfeldt A, Sw\u00e4rd P. Serum renin levels increase with age in boys resulting in higher renin levels in young men compared to young women, and soluble angiotensin-converting enzyme 2 correlates with renin and body mass index. Front Physiol. 2020 ;11:622179. https:\/\/doi.org\/10.3389\/fphys.2020.622179","journal-title":"Front Physiol"},{"key":"1245_CR19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1210\/clinem\/dgac568","volume":"108","author":"E Ng","year":"2022","unstructured":"Ng E, Gwini SM, Libianto R, Choy KW, Lu ZX, Shen J, et al. Aldosterone, renin, and aldosterone-to-renin ratio variability in screening for primary aldosteronism. J Clin Endocrinol Metab. 2022 ;108:33\u201341. https:\/\/doi.org\/10.1210\/clinem\/dgac568","journal-title":"J Clin Endocrinol Metab"},{"key":"1245_CR20","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC\/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018 ;39:3021\u2013104. https:\/\/doi.org\/10.1093\/eurheartj\/ehy339","journal-title":"Eur Heart J"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41371-026-01245-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-026-01245-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-026-01245-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:33:31Z","timestamp":1791822811000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41371-026-01245-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,12]]},"references-count":20,"alternative-id":["1245"],"URL":"https:\/\/doi.org\/10.1038\/s41371-026-01245-3","relation":{},"ISSN":["1476-5527"],"issn-type":[{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,12]]},"assertion":[{"value":"24 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The study was approved by the Ethics Committee of the People\u2019s Hospital of Xinjiang Uygur Autonomous Region (approval no. KY2026092901). All participants provided written informed consent. All methods were performed in accordance with the relevant guidelines and regulations, including the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}